Piramal Enterprises demerger call-off: 10 points to keep in mind before investing

Piramal Enterprises has called off its plan to demerge its pharma and financial services businesses.

The company had announced the demerger plan in 2018.

The decision to call off the demerger was taken due to the COVID-19 pandemic.

The company will now focus on strengthening its existing businesses.

Piramal Enterprises has a diversified business portfolio, including pharma, financial services, and real estate.

The company's pharma business has a strong presence in the US and India.

Piramal Enterprises' financial services business includes wholesale lending, housing finance, and asset management.

The company has a strong balance sheet with low debt-to-equity ratio.

Piramal Enterprises has a track record of successful acquisitions and partnerships.

The company's stock has been performing well in the market.

Investors should consider the company's long-term growth prospects before investing.

Investors should also keep an eye on any future developments related to the demerger plan.

For more such content